Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $526964.0.

  • Mangoceuticals' Accounts Payables fell 2551.95% to $526964.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $526964.0, marking a year-over-year decrease of 2551.95%. This contributed to the annual value of $837501.0 for FY2024, which is 49496.39% up from last year.
  • Per Mangoceuticals' latest filing, its Accounts Payables stood at $526964.0 for Q3 2025, which was down 2551.95% from $767996.0 recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' Accounts Payables registered a high of $1.2 million during Q1 2025, and its lowest value of $89059.0 during Q3 2023.
  • Over the past 3 years, Mangoceuticals' median Accounts Payables value was $713084.5 (recorded in 2024), while the average stood at $611278.4.
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 69443.85% in 2024, then crashed by 2551.95% in 2025.
  • Mangoceuticals' Accounts Payables (Quarter) stood at $140765.0 in 2023, then surged by 494.96% to $837501.0 in 2024, then plummeted by 37.08% to $526964.0 in 2025.
  • Its last three reported values are $526964.0 in Q3 2025, $767996.0 for Q2 2025, and $1.2 million during Q1 2025.